EUVIMEDEUVIMED entdecken
Crossref

Hyperglycemia-driven metabolic memory signaling destabilizes METTL1 to trigger inflammatory hypertrophy and fibrosis in diabetic cardiomyopathy

Yurui Yuan, Ang Zhang, Ying Jiang, Dayun Tao, Zhijiang Guo, Hang Zhu, Yu Zeng, Hongshuo Shi

Acta Diabetologica · 06.05.2026 · 63 (7) · 1211-1223

DOI: 10.1007/s00592-026-02699-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 06.05.2026. Verfasst von Yurui Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Sixth Medical Center of Chinese PLA General, Hospital, Fucheng Road, Haidian District, Beijing, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Hyperglycemia, Methyltransferases. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetic cardiomyopathy (DCM) occurs in the context of coronary artery disease or pressure overload heart disease, characterized by alterations in cardiac structure and function. The mechanisms linking metabolic memory and METTL1-mediated modifications to DCM progression remain unclear. METHODS: This study integrated multiple public transcriptome datasets to conduct a systematic analysis of gene expression profiles associated with diabetic cardiomyopathy. Potential key characteristic genes were identified through differential expression analysis and machine learning techniques. Their associated biological processes and signaling pathways were assessed using functional enrichment analysis. Additionally, single-cell RNA sequencing data were employed to examine the expression and distribution of key genes across various cardiac cell types, while gene set enrichment analysis (GSEA) was utilized to explore their potential functional networks. RESULTS: The integration of three public transcriptome datasets and subsequent differential expression analysis identified 159 genes associated with diabetic cardiomyopathy, of which 133 were upregulated and 26 downregulated. These differentially expressed genes (DEGs) effectively distinguished between DCM and control samples. Machine learning analyses, including LASSO regression and random forest, identified several key candidate genes, with METTL1 showing a significant association with inflammation, fibrosis, and metabolic disorders. In multiple independent datasets, METTL1 expression was markedly elevated in DCM samples and demonstrated substantial diagnostic potential (ROC AUC = 0.826). Functional enrichment analysis revealed that METTL1-related genes predominantly participated in pathways related to white blood cell migration, inflammatory activation, and extracellular matrix remodeling. Single-cell RNA sequencing further indicated that METTL1 was primarily enriched in the fibroblast population. The proportion of METTL1-positive fibroblasts in DCM samples was significantly increased and was associated with inflammatory and fibrosis-related signaling pathways. A comprehensive analysis suggests that METTL1 may play a role in the pathological progression of DCM by regulating fibroblast activation, amplifying inflammation, and contributing to myocardial remodeling. CONCLUSIONS: This study elucidates the expression characteristics of METTL1 and its potential regulatory functions in diabetic cardiomyopathy. The findings suggest that METTL1 metabolic memory may be influenced by RNA modifications occurring in the context of persistent inflammation and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesHyperglycemiaMethyltransferasesHumansFibrosisSignal TransductionInflammationGene Expression ProfilingTranscriptome

Stichwörter der Autor:innen

Diabetic cardiomyopathyMETTL1Single-cell RNA-sequencingfibrosismetabolic memory

Substanzen

Methyltransferases

Autor:innen und Institutionen

  • Department of Cardiology, the Sixth Medical Center of Chinese PLA General, Hospital, Fucheng Road, Haidian District, Beijing, China.
  • Guang'anmen Hospital, University of Göttingen, 100,053, Beijing, China.
  • Department of Cardiology, the Sixth Medical Center of Chinese PLA General, Hospital, Fucheng Road, Haidian District, Beijing, China. zhuhang301@outlook.com.
  • Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Beijing, China. lao03336662@163.com.
  • Shandong University of Traditional Chinese Medicine, Jinan, China. shihongshuo1@outlook.com.

Zitieren

APA

Yuan, Y., Zhang, A., Jiang, Y., Tao, D., Guo, Z., Zhu, H., Zeng, Y., & Shi, H. (2026). Hyperglycemia-driven metabolic memory signaling destabilizes METTL1 to trigger inflammatory hypertrophy and fibrosis in diabetic cardiomyopathy. Acta Diabetologica, 63(7), 1211-1223. https://doi.org/10.1007/s00592-026-02699-0

Vancouver

Yuan Y, Zhang A, Jiang Y, Tao D, Guo Z, Zhu H, et al. Hyperglycemia-driven metabolic memory signaling destabilizes METTL1 to trigger inflammatory hypertrophy and fibrosis in diabetic cardiomyopathy. Acta Diabetologica. 2026;63(7):1211-1223. doi:10.1007/s00592-026-02699-0

BibTeX
@article{Yuan2026,
  author = {Yuan, Yurui and Zhang, Ang and Jiang, Ying and Tao, Dayun and Guo, Zhijiang and Zhu, Hang and Zeng, Yu and Shi, Hongshuo},
  title = {Hyperglycemia-driven metabolic memory signaling destabilizes METTL1 to trigger inflammatory hypertrophy and fibrosis in diabetic cardiomyopathy},
  journal = {Acta Diabetologica},
  year = {2026},
  volume = {63},
  number = {7},
  pages = {1211--1223},
  doi = {10.1007/s00592-026-02699-0}
}
Kostenlos starten →